CBP Releases Guidance on the U.S.–EU Tariff Framework
.png)
The U.S.–EU tariff framework introduces new HTSUS provisions and exemptions that directly affect duty rates on autos, parts, and certain other EU imports.
SIMA Update: CBSA Adopts CARM as the Official System of Record for Re-determinations
Importers must now use the CARM Client Portal to submit re-determination requests for antidumping or countervailing duties within the 90-day deadline and provide the required supporting documentation.
CBSA Updates Guidance on the Courier Low Value Shipment (CLVS) Program
The updated CLVS Program aligns with CARM and reinforces compliance expectations. It provides clearer rules for importers and couriers, as well as a single framework to follow.
USDA-APHIS Clarifies Growing Media Exception for Canada Plant Imports
Plants imported into Canada in growing media may now qualify as Canadian origin for U.S. imports, provided they meet both U.S. and Canadian program requirements and are accompanied by proper documentation.
Canada Begins CUSMA Review Consultations in Advance of 2026 Talks
The consultations will help ensure that Canada’s position in the 2026 discussions is aligned with domestic economic interests and the needs of Canadian businesses.
Canada Extends Steel Import Permit Validity Effective September 11
The permit validity change builds on the measures introduced earlier this year, whereby Canada imposed a 50% surtax and TRQ limits on certain steel imports.
The White House Announces Modified Scope of Reciprocal Tariffs
In addition to expanding tariff exemptions to more than 45 goods, a new annex was established to outline potential tariff reductions under future trade agreements.
CBSA Amends Surtax Remission Order to Clarify Relief for U.S. Imports
The amendments offer Canadian importers temporary cost savings on U.S.-origin goods and relieve the impact of surtaxes on critical sectors such as health care, manufacturing, processing, and food packaging.
FDA Green List Established for Pharmaceutical Imports of GLP-1 APIs
The alert represents a new layer of oversight on pharmaceutical imports. It ensures that only FDA-reviewed sources are allowed to supply GLP-1 APIs to the U.S. market.
U.S. Imposes an Additional 25% Tariff on Indian Imports Over Russian Oil Ties
This measure doubles the overall tariff on many Indian goods to 50%, with exemptions for in-transit shipments, humanitarian items, Section 232 goods, reciprocal tariff products, and certain entries under Chapter 98.
